Literature DB >> 20014954

All-cause mortality and competing risks of fatal and nonfatal vascular events in the Italian longitudinal study on aging: impact of lipoprotein(a).

Vincenzo Solfrizzi1, Anna M Colacicco, Alessia D'Introno, Cristiano Capurso, Maria Chirico, Vincenza Frisardi, Maria Cacciapaglia, Gianluigi Vendemiale, Antonio Capurso, Francesco Panza.   

Abstract

Among possible determinants of vascular events, the role of high lipoprotein(a) (Lp[a]) serum levels represents a still uncertain independent risk factor in elderly populations. Moreover, the cumulative incidence of nonfatal vascular events due to high Lp(a) serum levels is conditioned by the competing risk of death from any causes that are a function of age. After a 6.3-year median follow up, we tested the competing risks of all-cause mortality, cumulative fatal-nonfatal stroke events, cumulative fatal-nonfatal coronary artery disease (CAD) events, and nonfatal stroke or CAD events due to high Lp(a) serum levels in a population-based, prospective study conducted in one of the eight centers of the Italian Longitudinal Study on Aging (ILSA), Casamassima, Bari, Italy. Of 704 elderly individuals (65-84 years), 372 (169 women and 203 men) agreed to participate in the study. As compared with those in the lowest Lp(a) tertile serum levels, subjects in the highest tertile (>20 mg/dL) had a higher partially adjusted risk of nonfatal CAD (hazard ratio, 4.19; 95% confidence interval [CI], 1.36-12.94) and nonfatal stroke (hazard ratio, 3.38; 95% CI, 1.00-11.56). Compared with those in the lowest tertile, subjects in the highest tertile had a higher fully adjusted risk of nonfatal CAD (hazard ratio, 3.41; 95% CI, 1.08-10.78). Finally, overall no statistically significant association was found between Lp(a) and the risk of all-cause mortality, cumulative fatal-nonfatal stroke, and cumulative fatal-nonfatal CAD events. In our population, Lp(a) was not a significant independent predictor of stroke and death from all causes, but it was an independent predictor of nonfatal CAD. Finally competing risk, conditioning the timing and occurrence of vascular events in our study population, could be a correct approach for evaluating the role of Lp(a) lipoprotein in vascular disease among elderly people.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20014954     DOI: 10.1089/rej.2009.0865

Source DB:  PubMed          Journal:  Rejuvenation Res        ISSN: 1549-1684            Impact factor:   4.663


  2 in total

Review 1.  Puzzling role of genetic risk factors in human longevity: "risk alleles" as pro-longevity variants.

Authors:  Svetlana Ukraintseva; Anatoliy Yashin; Konstantin Arbeev; Alexander Kulminski; Igor Akushevich; Deqing Wu; Gaurang Joshi; Kenneth C Land; Eric Stallard
Journal:  Biogerontology       Date:  2015-08-26       Impact factor: 4.277

Review 2.  The relationship between Lp(a) and CVD outcomes: a systematic review.

Authors:  Carol A Forbes; Ruben G W Quek; Sohan Deshpande; Gill Worthy; Robert Wolff; Lisa Stirk; Jos Kleijnen; Shravanthi R Gandra; Stephen Djedjos; Nathan D Wong
Journal:  Lipids Health Dis       Date:  2016-05-17       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.